FDA reviews AstraZeneca’s Saphnelo for subcutaneous use in Lupus
AstraZeneca & Daiichi Sankyo gain priority review for Datroway in hard-to-treat breast cancer
Eli Lilly posts blockbuster Q4 2025 results, issues bullish 2026 outlook
AbbVie posts higher revenue in 2025, led by immunology & neuroscience growth
Novo Nordisk weathers pricing pressure, bets big on oral Wegovy
Strides Pharma Inc receives USFDA closure report for Chestnut Ridge formulations facility
Lupin launches Topiramate ER capsules in US
Zydus receives FDA’s tentative approval for Dapagliflozin Tablets
Revvity posts higher Q4 earnings, lifts 2026 outlook as diagnostics strength offsets margin pressure
NATCO receives FDA's tentative approval for Erdafitinib tablets
The study tested whether PF’3944 could maintain efficacy when switching from weekly to monthly injections and remain safe and well-tolerated
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes